Literature DB >> 7577065

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.

M J Silverstein1, A Barth, D N Poller, E D Gierson, W J Colburn, J R Waisman, P Gamagami.   

Abstract

The 10-year results of 300 patients with ductal carcinoma in situ (DCIS) without microinvasion are reported; 167 treated with mastectomy and 133 treated with excision and radiation therapy. There was a significant difference in disease-free survival at 10 years, in favour of those treated with mastectomy, 98% versus 81% (P = 0.0004). Multivariate analysis confirmed nuclear grade as the only significant predictor of local recurrence (P = 0.02) or invasive local recurrence (P = 0.03) in patients with DCIS treated with excision and radiation therapy. There was no difference in breast cancer-specific survival or overall survival between the two treatment groups.

Entities:  

Mesh：

Year:  1995        PMID： 7577065     DOI： 10.1016/0959-8049(95)00283-o

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


  35 in total

1.  Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.

Authors:  Francesca Proulx; José A Correa; Romuald Ferré; Atilla Omeroglu; Ann Aldis; Sarkis Meterissian; Benoît Mesurolle
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

2.  Ductal Carcinoma in Situ: Clinical Perspective.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2010-08-02       Impact factor: 2.860

Review 3.  Ductal carcinoma in situ of the breast.

Authors:  M J Silverstein
Journal:  BMJ       Date:  1998-09-12

4.  A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.

Authors:  Ying Liu; Maria Pérez; Mario Schootman; Rebecca L Aft; William E Gillanders; Matthew J Ellis; Donna B Jeffe
Journal:  Breast Cancer Res Treat       Date:  2010-05-06       Impact factor: 4.872

5.  The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.

Authors:  Donna B Jeffe; Maria Pérez; Emily F Cole; Ying Liu; Mario Schootman
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

Review 6.  Current Therapeutic Approaches to DCIS.

Authors:  Kaleigh Doke; Shirley Butler; Melissa P Mitchell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-29       Impact factor: 2.673

Review 7.  Ductal carcinoma in situ of breast: update 2019.

Authors:  Sunil S Badve; Yesim Gökmen-Polar
Journal:  Pathology       Date:  2019-08-28       Impact factor: 5.306

8.  Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

Authors:  D Craig Allred; Stewart J Anderson; Soonmyung Paik; D Lawrence Wickerham; Iris D Nagtegaal; Sandra M Swain; Elefetherios P Mamounas; Thomas B Julian; Charles E Geyer; Joseph P Costantino; Stephanie R Land; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

9.  Clinical experience of patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery plus radiotherapy: a preliminary report.

Authors:  Ji-Young Jang; Mi-Ryeong Ryu; Sung-Whan Kim; Chul-Seung Kay; Yeon-Sil Kim; Yoon-Kyeong Oh; Hyung-Chul Kwon; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

Review 10.  Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.

Authors:  Ute Kettritz
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.